Insulin Maker Offering 90-Day Supply For Diabetics Impacted By COVID-19
An insulin maker is offering diabetics a 90-day supply if they recently lost their jobs due to the COVID-10 pandemic and therefore no longer have health insurance.
Novo Nordisk Inc. announced through a press release that its current customers will be eligible for the offer through the company's Diabetes Patient Assistance Program (PAP).
"The pandemic is taking a serious toll on the nation's health and economy. Millions of people are losing jobs and health coverage, and that's especially tragic if you have a chronic disease like diabetes. We already have a lot of programs to help people afford insulin but the impact of COVID-19 goes beyond that. We know people need more help right now and we want to do something that could make an immediate difference. We also want to dial-up our efforts to make people aware of the help that is available," said Doug Langa, Executive Vice President, North America Operations and President of Novo Nordisk Inc.
There are a few things to keep in mind: You must have a valid prescription for Novo Nordisk insulin and meet certain eligibility criteria. Applicants are not required to provide documented proof of income. However, participants must provide documentation showing loss of healthcare benefits, such as a job termination notice or job status change, or proof that COBRA benefits are being offered.
Novo Nordisk Inc.says that if Medicaid benefits are denied, assistance for eligible patients can be extended past the 90-day-window until the end of the year.
"Patients have enough issues to worry about at this moment. We don't want being able to pay for their insulin to be one of them," says Langa.